Top

Internal and Emergency Medicine

Published in:

01-10-2020 | Myocardial Infarction | CE-Research Letter to the Editor

Lack of utility of CK-MB in combination with troponin I for the diagnosis of acute coronary syndrome

Authors: Silvia Baroni, Maurizio Gabrielli, Federica Ferrigno, Francesco Franceschi, Andrea Urbani

Published in: Internal and Emergency Medicine | Issue 7/2020

Excerpt

Dear Editor, …

Amsterdam EA, Wenger NK, Brindis RG et al (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130(25):e344–e426. https://doi.org/10.1161/CIR.0000000000000134CrossRefPubMed

Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315. https://doi.org/10.1093/eurheartj/ehv320CrossRefPubMed

Newby LK, Roe MT, Chen AY et al (2006) Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol 47(2):312–318. https://doi.org/10.1016/j.jacc.2005.08.062CrossRefPubMed

Goodman SG, Steg PG, Eagle KA, Fox KA et al (2006) The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 151(3):654–660. https://doi.org/10.1016/j.ahj.2005.05.014CrossRefPubMed

Collinson P, Hammerer-Lercher A, Suvisaari J et al (2016) How well do laboratories adhere to recommended clinical guidelines for the management of myocardial infarction: the CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE). Clin Chem 62(9):1264–1271. https://doi.org/10.1373/clinchem.2016.259515CrossRefPubMed

Alvin MD, Jaffe AS, Ziegelstein RC, Trost JC (2017) Eliminating creatine kinase-myocardial band testing in suspected acute coronary syndrome: a value-based quality improvement. JAMA Intern Med. 177(10):1508–1512. https://doi.org/10.1001/jamainternmed.2017.3597CrossRefPubMed

Kim J, Hashim IA (2016) The clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome. Clin Chim Acta 456:89–92. https://doi.org/10.1016/j.cca.2016.02.030CrossRefPubMed

Le RD, Kosowsky JM, Landman AB et al (2015) Clinical and financial impact of removing creatine kinase-MB from the routine testing menu in the emergency setting. Am J Emerg Med 33(1):72–75. https://doi.org/10.1016/j.ajem.2014.10.017CrossRefPubMed

Title: Lack of utility of CK-MB in combination with troponin I for the diagnosis of acute coronary syndrome
Authors: Silvia Baroni
Maurizio Gabrielli
Federica Ferrigno
Francesco Franceschi
Andrea Urbani
Publication date: 01-10-2020
Publisher: Springer International Publishing
Keywords: Myocardial Infarction
Acute Coronary Syndrome
Published in: Internal and Emergency Medicine / Issue 7/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02399-9

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2020

Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

Understanding and improving decisions in clinical medicine (V): Jekyll and Hyde, the two faces of clinical reasoning

The assessment of dermatological emergencies in the emergency department via telemedicine is safe: a prospective pilot study

The HEART score as a prognostic tool for revascularization: comment

Approaching acute pain in emergency settings: European Society for Emergency Medicine (EUSEM) guidelines—part 1: assessment

Characteristics of current heart failure patients admitted to internal medicine vs. cardiology: are we still caring for two different populations?

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage